Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies

Kyle W. Singleton, Alyx B. Porter, Leland S. Hu, Sandra K. Johnston, Kamila M. Bond, Cassandra R. Rickertsen, Gustavo De Leon, Scott A. Whitmire, Kamala R. Clark-Swanson, Maciej M. Mrugala, Kristin R. Swanson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences